Abstract
Renal diseases associated with nephrotic syndrome (NS) in the first year of life are uncommon and make up a heterogeneous group of disorders [73]. Congenital nephrotic syndrome (CNS) is defined as proteinuria manifesting in the first 3 months of life. NS appearing later during the first year (4–12 months) is defined infantile, and NS manifesting thereafter is called childhood NS. While this classification is used to help the clinical diagnosis, it is arbitrary in the sense that NS caused by a specific gene mutation can manifest soon after birth or later in life. However, since the management of CNS is often different from the more common forms of childhood NS, the terminology still seems warranted (Table 1).
Similar content being viewed by others
References
Alamiz-Echevarria L, Vallo A, Aguire M, et al. Essential fatty acid deficiency profile in patients with nephrotic-range proteinuria. Pediatr Nephrol. 2007;22:533–40.
Antikainen M. Protein and lipid metabolism in nephrotic infants on peritoneal dialysis. Pediatr Nephrol. 1993;7:428–53.
Antikainen M, Holmberg C, Taskinen M. Growth, serum lipoproteins an apoproteins in infants with congenital nephrosis. Clin Nephrol. 1992;38:254–63.
Antikainen M, Sariola H, Rapola J, et al. Pathology of renal arteries of dyslipidemic children with congenital nephrosis. APMIS. 1994;102:129–34.
Aula P, Rapola J, Karjalainen O, et al. Prenatal diagnosis of congenital nephrosis in 23 high-risk families. Am J Dis Child. 1978;132:984–7.
Avni E, Vanhdenhoute K, Devriendt A, et al. Update on congenital nephrotic syndromes and contribution of US. Pediatr Radiol. 2011;41:76–81.
Aya K, Tanaka H, Seino Y. Novel mutation in the nephrin gene of a Japanese patient with congenital nephrotic syndrome of the Finnish type. Kidney Int. 2000;57:401–4.
Barakat A, Papadoupoulo Z, Chana R, et al. Pseudohermaphroditism, nephron disorder an Wilms tumor: a unifying concept. Pediatrics. 1974;54:366–9.
Barbaux S, Niaudet P, Gubler M-C, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet. 1997;17:467–70.
Barletta GM, Kovari I, Verma R, et al. Nephrin and Neph1 co-localize at the podocyte foot process intercellular junction and form cis hetero-oligomers. J Biol Chem. 2003;278:19266–71.
Barua M, Brown E, Charoonratana V, et al. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis. Kidney Int. 2013;83:316–22.
Basker M, Agarwal I, Benon K. Congenital nephrotic syndrome- a treatable cause. Ann Trop Paediatr. 2007;27:87–90.
Baskin E, Bayracki U, Alehan F, et al. Respiratory chain deficiency presenting as diffuse mesangial sclerosis with NPHS3 mutation. Pediatr Nephrol. 2011;26:1157–61.
Batisky F, Roy S, Gaber L. Congenital nephrosis and neonatal cytomegalovirus infection: a clinical association. Pediatr Nephrol. 1993;7:741–3.
Becker-Cohen R, Bruschi M, Rinat C, et al. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am J Transplant. 2007;7:256–60.
Beltcheva O, Lenkkeri U, Kestilä M, et al. Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Hum Mutat. 2001;17:368–73.
Benfield M, McDonald R, Bartosh S, et al. Changing trends in pediatric transplantation: 2001 Annual Report of the North American Pediatric renal transplant cooperative study. Pediatr Transplant. 2003;7:321–31.
Benoit G, Machuca E, Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol. 2010;25:1621–32.
Benzing T. Signalling in the slit diaphragm. J Am Soc Nephrol. 2004;15:1382–91.
Besbas N, Bayrakei U, Kale G, et al. Cytomegalovirus-related congenital nephrotic syndrome with diffuse mesangial sclerosis. Pediatr Nephrol. 2006;21:740–2.
Bongers E, Gubler M, Knoers N. Nail-patella syndrome. Overview on clinical and molecular findings. Pediatr Nephrol. 2002;17:703–12.
Bolk S, Puffenberger EG, Hudson J, et al. Elevated frequency and allelic heterogeneity of congenital nephrotic syndrome, Finnish type, in the old order Mennonites. Am J Hum Genet. 1999;65:1785–90.
Boute N, Gribouval O, Roselli S, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000;24:349–54.
Boyer O, Benoit G, Gribouval O. Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011;22:239–45.
Boyer O, Benoit G, Gribouval O, et al. Mutational analysis f the PLC1 gene in steroid resistant nephrotic syndrome. J Med Genet. 2010;47:445–52.
Brady T, Mitra A, Hooks J. Maternal serum alpha-fetoprotein level peak at 19–21 weeks’ gestation and subsequently decline in a NPHS1 sequence variant heterozygote; implications for prenatal diagnosis of congenital nephrosis of the Finnish type. Prenat Diagn. 2014;34:1–3.
Brown E, Schlondorff J, Becker D, et al. Mutations in the formin protein INF2 cause focal segmental glomerulosclerosis. Nat Genet. 2010;42:72–6.
Buscher A, Kranz B, Buscher R, et al. Immunosuppression and renal outcome in congenital and pediatric steroid resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2010;5:2075–84.
Call K, Glaser T, Ito C, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell. 1990;60:509–20.
Caridi G, Bertelli R, Carrea A, et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol. 2001;12:2742–6.
Caridi G, Bertelli R, Di Duca M, et al. Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol. 2003;14:1278–86.
Caridi G, Dagnino M, Carrea A, et al. Lack of cardiac anomalies in children with NPHS2 mutations. Nephrol Dial Transplant. 2007;22:1477–8.
Chadha V, Alon U. Bilateral nephrectomy reverses hypothyroidism in congenital nephrotic syndrome. Pediatr Nephrol. 1999;13:209–11.
Chaib H, Hoskins B, Ashraf S, et al. Identification of BRAF as a new interactor of PLCE1, the protein mutated in nephrotic syndrome type 3. Am J Physiol Renal Physiol. 2008;294:F93–9.
Chen Y, Zhou Y, Go G, et al. Laminin β2 gene missense mutation produces endoplasmic reticulum stress in podocytes. J Am Soc Nephrol. 2013;24:1223–33.
Choi H, Lee B, Kang J, et al. Variable phenotype of Pierson syndrome. Pediatr Nephrol. 2008;23:995–1000.
Copelovitch L, Guttenberg M, Pollak M, Kaplan B. Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS. Pediatr Nephrol. 2007;22:1779–84.
Coppes M, Huff V, Pelletier J. Denys–Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr. 1993;123:673–8.
Coulthard M. Management of Finnish congenital nephrotic syndrome by unilateral nephrectomy. Pediatr Nephrol. 1989;3:451–3.
Crecka A, Mundel P. Cell biology and pathology of podocytes. Annu Rev Physiol. 2012;74:299–323.
Dagan A, Cleper R, Krause I, et al. Hypothyroidism in children with steroid-resistant nephrotic syndrome. Nephrol Dial Transplant. 2012;27:2171–5.
Dámico G, Bazi C. Pathophysiology of proteinuria. Kidney Int. 2003;63:809–25.
Debiecic H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002;346:2053–60.
Denys P, Malvaux P, Van den Berghe H, et al. De pseudohermaphrodisme masculin, d’une tumeur de Wilms, d’une néphropathie parenchymateuse et d’une mosaicisme XX/XY. Arch Fr Pediatr. 1967;24:729–39.
Diomedi-Camassei F, Giandomenico S, Santorelli F, et al. COQ2 Nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol. 2007;18:2773–80.
Donoviel D, Freed D, Vogel H, et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to nephrin. Mol Cell Biol. 2001;21:4829–36.
Drash A, Sherman F, Hartmann W, Blizzard R. A syndrome of pseudohermaphroditism, Wilms’ tumor, hypertension, and degenerative renal disease. J Pediatr. 1970;76:585–93.
Dudley J, Fenton T, Unsworth J, et al. Systemic lupus erythematosus presenting as congenital nephrotic syndrome. Pediatr Nephrol. 1996;10:752–5.
Eddy A, Mauer S. Pseudohermaphroditism, glomerulopathy, and Wilms’ tumor (Drash syndrome): frequency in end-stage renal failure. J Pediatr. 1985;106:584–7.
Esterly J, Oppenheimer E. Pathological lesions due to congenital rubella. Arch Pathol. 1969;87:380–8.
Frishberg Y, Feinstein S, Rinat C, et al. The heart of children with steroid-resistant nephrotic syndrome; is it all podocin? J Am Soc Nephrol. 2006;17:227–31.
Frishberg Y, Rinat C, Megged O, et al. Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. J Am Soc Nephrol. 2002;13:400–5.
Galloway W, Mowat A. Congenital microcephaly with hiatus hernia and nephrotic syndrome in two sibs. J Med Genet. 1968;5:319–21.
Garty B, Eisenstein B, Sanbank J, et al. Microcephaly an congenital nephrotic syndrome owing to diffuse mesangial sclerosis: an autosomal recessive syndrome. J Med Genet. 1994;31:121–5.
Gavin L, McMahon F, Castle I, et al. Alterations in serum thyroid hormones an thyroxin-binding globulin in patients with nephrosis. J Clin Endocrinol Metab. 1978;46:125–30.
Gellerman J, Stefabidis C, Mitsioni A, Querfeld U. Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations. Pediatr Nephrol. 2010;25:2051–3.
Gee H, Saisawat P, Ashraf S, et al. ARHDGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest. 2013;123:3243–53.
Gerke P, Huber T, Sellin L, et al. Homodimerization and heterodimerization of the glomerular podocyte proteins nephrin and NEPH1. J Am Soc Nephrol. 2003;14:918–26.
Gessler M, Poustka A, Cavenee W, et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343:774–8.
Gbadegesin R, Bartkowiak B, Lavin P, et al. Exclusion of homozygous PLCE1 (NPHS3) mutations in 69 families with idiopathic and hereditary FSGS. Pediatr Nephrol. 2009;24:281–5.
Gbadegesin R, Hinkes B, Hoskins B, et al. Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant. 2008;23:1291–7.
Giglio S, Provenzano A, Mazzinghi B. Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J Am Soc Nephrol. 2014;10:e1004262.
Gilbert R, Turner C, Gibson J, et al. Mutations in phospholipase C epsilon 1 are not sufficient to cause diffuse mesangial sclerosis. Kidney Int. 2009;75:415–9.
Gilbert R, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol. 1994;8:11–4.
Goldenberg A, Ngoc L, Thouret M, et al. Respiratory chain deficiency presenting as congenital nephrotic syndrome. Pediatr Nephrol. 2005;20:465–9.
Grahammer F, Schell C, Huber T. The podocyte slit diaphragm – from a thin grey line to complex signalling hub. Nat Rev Nephrol. 2013;9:587–98.
Grech V, Chan M, Vella C, et al. Cardiac malformations associated with congenital nephrotic syndrome. Pediatr Nephrol. 2000;14:1115–7.
Guez S, Giani M, Melzi M, et al. Adequate clinical control of congenital nephrotic syndrome by enalapril. Pediatr Nephrol. 1998;12:130–2.
Guo JK, Menke A, Gubler M, et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet. 2002;11:651–9.
Gupta I, Baldwin C, Auguste D, et al. ARHGDIA, novel gene implicated in nephrotic syndrome. J Med Genet. 2013;50:330–8.
Haavisto A, Jalanko H, Sintonen H, et al. Quality of life in adult survivors of pediatric kidney transplantation. Transplantation. 2011;92:1322–6.
Haavisto A, Korkman M, Holmberg C, et al. Neuropsychological profile of children with kidney transplants. Nephrol Dial Transplant. 2012;27:2594–601.
Habib R. Nephrotic syndrome in the 1st year of life. Pediatr Nephrol. 1993;7:347–53.
Hahn H, Cho Y, Park Y, et al. Two cases of isolate diffuse mesangial sclerosis with WT1 mutations. J Korean Med Sci. 2006;21:160–4.
Hallman N, Hjelt L, Ahvenainen EK. Nephrotic syndrome in newborn and young infants. Ann Paediatr Fenn. 1956;2:227–41.
Hameed R, Raafat F, Ramani P, et al. Mitochondrial cytopathy presenting with focal segmental glomerulosclerosis, hypoparathyroidism, sensorineural deafness, and progressive neurological disease. Postgrad Med J. 2001;77:523–6.
Hameed R, Shomaf M. Congenital nephrotic syndrome: a clinico-pathological study of thirty children. J Nephrol. 2001;14:104–9.
Hasselbacher K, Wiggins R, Matejas V, et al. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int. 2006;70:1008–12.
Hata D, Miyazaki M, Seto S, et al. Nephrotic syndrome and aberrant expression of laminin isoforms in glomerular basement membranes for infant with herlitz junctional epidermolysis bullosa. Pediatrics. 2005;116:e601–7.
Heidet L, Bongers E, Sich M, et al. In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys. Am J Pathol. 2003;163:145–55.
Heaton PA, Smales O, Wong W. Congenital nephrotic syndrome responsive to captopril and indomethacin. Arch Dis Child. 1999;81:174–5.
Heeringa S, Chernin G, Chaki M, et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest. 2011;121:2013–24.
Heeringa S, Vlangos C, Chernin G, et al. Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome. Nephrol Dial Trasnplant. 2008;23:3527–33.
Hinkes B. NPHS3: new clues for understanding idiopathic nephrotic syndrome. Pediatr Nephrol. 2008;23:847–50.
Hinkes B, Mucha B, Vlangos C, et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, LAMB2). Pediatrics. 2007;119:e907–19.
Hinkes B, Vlangos C, Heeringa S, et al. Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2008;19:365–71.
Hinkes B, Wiggins R, Gbadegesin R, et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet. 2006;38:1397–405.
Holmberg C, Antikainen M, Ronnholm K, et al. Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol. 1995;9:87–93.
Holmberg C, Jalanko H. Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation. Pediatr Nephrol. 2014;29:2309–17.
Holtta T, Happonen J, Ronnholm K, et al. Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol. 2001;16:324–31.
Holtta T, Ronnholm K, Jalanko H, Holmberg C. Clinical outcome of pediatric patients on peritoneal dialysis under adequacy control. Pediatr Nephrol. 2000;11:88–98.
Holzman L, St John P, Kovari I, et al. Nephrin localizes to the slit pore of the glomerular epithelial cell. Kidney Int. 1999;56:1481–91.
Hu M, Zhang G, Arbuckle S, et al. Prophylactic bilateral nephrectomies in two pediatric patients with missense mutations in the WT1 gene. Nephrol Dial Transplant. 2004;19:223–6.
Huber T, Harteleben B, Kim J, et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT dependent signalling. Mol Cell Biol. 2003;23:4917–28.
Huber T, Kottgen M, Schilling B, et al. Interaction with podocin facilitates nephrin signaling. J Biol Chem. 2001;276:41543–6.
Huttunen N-P. Congenital nephrotic syndrome of Finnish type: study of 75 patients. Arch Dis Child. 1976;51:344–8.
Inoue T, Yaoita E, Kurihara H, et al. FAT is a component of glomerular slit diaphragms. Kidney Int. 2001;59:1003–12.
Ismaili K, Verure V, Vanenhoute K, et al. WT1gene mutations in three girls with nephrotic syndrome. Eur J Pediatr. 2008;167:579–81.
Ito S, Takata A, Hataya H, et al. Isolated diffuse mesangial sclerosis and Wilms’ tumor suppressor gene. J Pediatr. 2001;138:425–8.
Jalanko H. Congenital nephrotic syndrome. Pediatr Nephrol. 2009;24:2121–8.
Jalanko H, Holmberg C. Renal transplantation in infants. Pediatr Nephrol. 2014 (in press)
Jalanko H, Patrakka J, Tryggvason K, et al. Genetic kidney diseases disclose the pathogenesis of proteinuria. Ann Med. 2001;33:526–33.
Jarad G, Cunningham J, Shaw A, Miner J. Proteinuria precedes podocyte abnormalities in Lamb2 mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest. 2006;116:2272–9.
Jeanpierre C, Denamur E, Henry I, et al. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of computerized mutation database. Am J Hum Genet. 1998;62:824–33.
Jefferson J, Shankland S. Familial nephrotic syndrome: PLCE1 enters the fray. Nephrol Dial Transplant. 2007;22:1849–52.
Jones N, Blasutig I, Eremina V, et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature. 2006;440:818–23.
Kagan M, Cohen A, Matejas V, et al. A milder variant of Pierson syndrome. Pediatr Nephrol. 2008;23:323–7.
Kaplan JM, Kim SH, North K, et al. Mutations in ACTN4, encoding α-actinin-4 cause familial-focal segmental glomerulosclerosis. Nat Genet. 2000;24:251–6.
Karle S, Uetz B, Ronner V, et al. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2002;13:388–93.
Kaukinen A, Kuusniemi AM, Lautenschaleger I, et al. Glomerular endothelium in kidneys with congenital nephrotic syndrome (NPHS1). Nephrol Dial Transplant. 2008;23:1224–32.
Kawachi H, Miyauchi N, Suzuki K, et al. Role of podocyte slit diaphragm as a filtration barrier. Nephrology. 2006;11:274–81.
Kestilä M, Lenkkeri U, Männikkö M, et al. Positionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome. Mol Cell. 1998;1:575–82.
Khurana S, Chakraborty S, Lam M, et al. Familial focal segmental glomerulosclerosis (FSGS)-linked a-actin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. J Biol Chem. 2012;287:12027–35.
Klamt B, Koziell A, Poulat F, et al. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/−KTS splice isoforms. Hum Mol Genet. 1998;7:709–14.
Kopp J, Smith M, Nelson G, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008;40:1175–84.
Kovacevic L, Reid C, Ridgen S. Management of congenital nephrotic syndrome. Pediatr Nephrol. 2003;18:426–30.
Koziell A, Grech V, Hussain S, et al. Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet. 2002;11:379–88.
Krishnamurthy S, Rajesh N, Ramesh A, Zenker M. Infantile nephrotic syndrome with microcephaly and global developmental delay: the Galloway Mowat syndrome. Indian J Pediatr. 2012;79:1087–90.
Kuusniemi AM, Kestilä M, Patrakka J, et al. Tissue expression of nephrin in man and pig. Pediatr Res. 2004;55:774–81.
Kuusniemi A, Lapatto R, Holmberg C, et al. Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change. Kidney Int. 2005;68:121–32.
Kuusniemi A-M, Qvist E, Sun Y, et al. Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type. Transplantation. 2007;83:1316–23.
Kuusniemi A, Merenmies J, Lahdenkari AT, et al. Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1). Kidney Int. 2006;70:1423–31.
Laakkonen H, Hölttä T, Lönnqvist T, et al. Peritoneal dialysis in children under two years of age. Nephrol Dial Transplant. 2008;23:1747–53.
Lahdenkari AT, Lounatmaa K, Patrakka J, et al. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol. 2004;15:2611–8.
Lehtonen S. Connecting the interpodocyte slit diaphragm and actin dynamics: emerging role for the nephrin signalling complex. Kidney Int. 2008;73:903–5.
Lennert T, Härtling A, Mildenberger E, et al. Augenveränderung be diffuser mesangialer Sklerose (DMS). Monatschr Kinederheilkd. 1997;145:209–12.
Llach F, Papper S, Massry S. The clinical spectrum of renal vein thrombosis. Am J Med. 1980;69:819–27.
Little M, Wells C. A clinical overview of WT1 gene mutations. Hum Mutat. 1997;9:209–25.
Litwin M, Grena R, Slaowska J, et al. Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol. 2006;21:1716–22.
Liu L, Done S, Khoshnoodi J, et al. Defective nephrin trafficking caused by missense mutations in the NPHS1 gene: insight into the mechanisms of congenital nephrotic syndrome. Hum Mol Genet. 2001;10:2637–44.
Ljungberg P, Holmberg C, Jalanko H. Infections in infants with congenital nephrosis of the Finnish type. Pediatr Nephrol. 1997;11:148–52.
Lovric S, Fang H, Vega-Warner V, et al. Rapid detection of monogenic causes of childhood-onset steroid resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2014;9:1109–16.
Machuca E, Benoit G, Nevo F, et al. Genotype-Phenotype correlations in non-Finnish congenital nephrotic syndrome. J Am Soc Nephrol. 2010;21:1209–17.
Malina M, Cinek O, Janda J, Seeman T. Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutations. Pediatr Nephrol. 2009;24:2051–3.
Martin-Hernandez E, Garcia-Silva T, Vara J, et al. Renal pathology in children with mitochondrial diseases. Pediatr Nephrol. 2005;20:1299–305.
Matejas V, Hinkes B, Alkandari F, et al. Mutations in the human laminin β2 (LAMB2) gene and the associated phenotype. Hum Mutat. 2010;31:992–1002.
Matejas V, Al-Gazali L, Amirlak I, Zenker M. A syndrome comprising childhood-onset glomerular kidney disease and ocular abnormalities with progressive loss of vision is caused but mutated LAMB2. Nephrol Dial Transplant. 2006;21:3283–6.
Mathias R, Stecklein H, Guay-Woodford L, et al. Gamma globulin deficiency in newborns with congenital nephrotic syndrome. N Engl J Med. 1989;320:398–9.
Mattoo T, Al-Sowailem A, Al-Harbi M. Nephrotic syndrome in the 1st year of life and the role of unilateral nephrectomy. Pediatr Nephrol. 1992;6:16–8.
McCarthy H, Bierzynska A, Wherlock M, et al. Simultaneous sequencing of 24 genes associated with steroid resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2013;8:637–48.
McLean R, Kennedy T, Rosoulpour M, et al. Hypothyroidism in the congenital nephrotic syndrome. J Pediatr. 1982;101:72–5.
Mele C, Iatropulos P, Donadelli R, et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Eng J med. 2011;365:295–306.
Meyers K, Kaplan P, Kaplan B. Nephrotic syndrome, microcephaly, and developmental delay: three separate syndromes. Am J Med Genet. 1999;82:257–60.
Moeller M, Kovari I, Holzman L. Evaluation of a new tool for exploring podocyte biology: mouse NPHS1 5-flanking region drives LacZ expression in podocytes. J Am Soc Nephrol. 2000;11:2306–14.
Mrowka C, Schedl A. Wilms’ tumor suppressor gene WT1: from structure to renal pathophysiologic features. J Am Soc Nephrol. 2000;11:S106–15.
Natoli T, Liu J, Eremina V, et al. A mutant form of the Wilms’ tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol. 2002;13:2058–67.
Niaudet P. Genetic forms of nephrotic syndrome. Pediatr Nephrol. 2004;19:1313–8.
Niaudet P, Gubler M-C. WT1 and glomerular diseases. Pediatr Nephrol. 2006;21:1653–60.
Nicolaou N, Margadant C, Kevelam S, et al. Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome. J Clin Invest. 2012;122:4375–87.
Nielsen K, Steffensen G. Congenital nephrotic syndrome associated with Lowe’s syndrome. Child Nephrol Urol. 1990;10:92–5.
Niemsiri S. Congenital syphilitic nephrosis. Southeast Asian J Trop Med Public Health. 1993;24:595–600.
Nishibori Y, Liu L, Hosoyamada M, et al. Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int. 2004;66:1755–65.
Nishikawa M, Ichiyama T, Hayashi T, et al. A case of early myoclonic encephalopathy with the congenital nephrotic syndrome. Brain Dev. 1997;19:144–7.
Norio R. Heredity in the congenital nephrotic syndrome: a genetic study of 57 Finnish families with a review of reported cases. Ann Paediatr Fenn. 1966;12:27–32.
Nortier J, Debiec H, Tournay Y, et al. Neonatal disease in neutral endopeptidase alloimmunization: lessons for immunological monitoring. Pediatr Nephrol. 2006;21:1399–405.
Ovunc B, Ashraf S, Vega-Warner V, et al. Mutation analysis of NPHS1 in a worldwide cohort of congenital nephrotic syndrome patients. Nephron Clin Pract. 2012;120:139–46.
Ozcakar Z, Cenzig F, Cakar N, et al. Analysis of NPHS2 mutations in Turkish steroid-resistant nephrotic syndrome patients. Pediatr Nephrol. 2006;21:1093–6.
Pannicucci F, Sagripanti A, Vispi M, et al. Comprehensive study of hemostasis in congenital nephrotic syndrome. Nephron. 1983;33:9–13.
Patrakka J, Kestilä M, Wartiovaara J, et al. Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients. Kidney Int. 2000;58:972–80.
Patrakka J, Martin P, Salonen R, et al. Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations. Lancet. 2002;359:1575–7.
Patrakka J, Ruotsalainen V, Reponen V, et al. Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. Transplantation. 2002;73:394–403.
Pelletier J, Bruening W, Kashtan C, et al. Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991;67:437–47.
Philippe A, Nevo F, Esquivel E, et al. Nephrin mutations can cause childhood-onset steroid resistant nephrotic syndrome. J Am Soc Nephrol. 2008;19:1871–8.
Pomeranz A, Wolach B, Bernheim J, Korzets Z. Successful treatment of Finnish type congenital nephrotic syndrome with captopril and indomethacin. J Pediatr. 1995;126:140–2.
Putaala H, Soininen R, Kilpelainen P, et al. The murin nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet. 2001;10:1–8.
Qvist E, Laine J, Rönnholm K, et al. Graft function 5–7 years after renal transplantation in early childhood. Transplantation. 1999;67:1043–9.
Qvist E, Krogerus L, Rönnholm K, et al. Course of renal allograft histopathology after transplantation in early childhood. Transplantation. 2000;70:480–7.
Qvist E, Marttinen E, Rönnholm K, et al. Growth after renal transplantation in infancy or early childhood. Pediatr Nephrol. 2002;17:438–43.
Qvist E, Pihko H, Fagerudd P, et al. Neurodevelopmental outcome in high-risk patients after renal transplantation in early childhood. Pediatr Transplant. 2002;6:53–62.
Rahman H, Begum A, Jahan S, et al. Congenital nephrotic syndrome, an uncommon presentation of cytomegalovirus infection. Mymesingh Med J. 2008;17:210–3.
Ramsuran D, Bhimma R, Randial P, et al. The spectrum of HIV-related nephropathy in children. Pediatr Nephrol. 2012;27:821–7.
Rapola J, Savilahti E. Immunofluorescent and morphological studies in congenital nephrotic syndrome. Acta Paediatr. 1971;60:253–63.
Roselli S, Gribouval O, Boute G, et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol. 2002;160:3–5.
Ruotsalainen V, Ljungberg P, Wartiovaara J, et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A. 1999;96:7962–7.
Ruotsalainen V, Patrakka J, Tissari P, et al. Role of nephrin in cell junction formation in human nephrogenesis. Am J Pathol. 2000;157:1905–16.
Ruf R, Lichtenberger A, Karle S, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol. 2004;15:722–32.
Ruf R, Schultheiss M, Lichtenberger A, et al. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int. 2004;66:564–70.
Sako M, Nakanishi K, Obana M, et al. Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int. 2005;67:1248–55.
Salvatierra O, Sarwal M. Renal perfusion in infant recipients of adult sized kidneys is critical risk factor. Transplantation. 2000;70:412–3.
Salviati L, Sacconi S, Murer L, et al. Infantile encephalomyopathy an nephropathy with CoQ10 efficiency: A CoQ10-responsive condition. Neurology. 2005;65:606–8.
Sanna-Cherchi S, Burgess K, Nees S, et al. Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. Kidney Int. 2011;80:389–96.
Sano H, Miyanoshita A, Watanabe N, et al. Microcephaly an early-onset nephrotic syndrome: a case report. Pediatr Nephrol. 1995;9:711–4.
Santini S, Bullich G, Tazon-Vega B, et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2011;6:1139–48.
Santini S, Garcia-Maset R, Ruiz P, et al. Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis. Kidney Int. 2009;76:1268–76.
Savage J, Jefferson J, Maxwell A, et al. Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families. Arch Dis Child. 1999;80:466–9.
Scaleis E, Chafai R, van Coster R, et al. Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). Eur J Pediatr. 2013;17:625–30.
Schoeb D, Cernin G, Heeringa S, et al. Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS). Nephrol Dial Transplant. 2010;25:2970–7.
Schultheiss M, Ruf R, Mucha B, et al. No evidence for genotype/phenotype correlation in NPHS1 and NPH2 mutations. Pediatr Nephrol. 2004;19:1340–8.
Schumacher V, Scharer K, Wuhl E, et al. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int. 1998;53:1594–600.
Schwarz K, Simons M, Reiser J, et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest. 2001;108:1621–9.
Sellin L, Huber T, Gerke P, et al. NEPH1 defines a novel family of podocin interacting proteins. FASEB J. 2003;17:115–7.
Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine. 2003;82:203–15.
Shahin B, Papaopoulous Z, Jenis E. Congenital nephrotic syndrome associate with congenital toxoplasmosis. J Pediatr. 1997;85:366–72.
Shih N, Karpitskii V, Nguyen A, et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science. 1999;286:312–5.
Sinha M, Horsfield C, Komaromy B, et al. Congenital disorders of glycosylation: a rare cause of nephrotic syndrome. Nephrol Dial Transplant. 2009;24:2591–4.
Sperl W, Gruber W, Quatacker J, et al. Nephrosis in two siblings with infantile sialic acid storage disease. Eur J Pediatr. 1990;149:477–82.
Srivastava T, Whiting J, Garola R, et al. Podocyte proteins in Galloway-Mowat syndrome. Pediatr Nephrol. 2001;16:1022–9.
Stoll R, Lee B, Debler E, et al. Structure of the Wilms tumor suppressor protein zinc finger domain bound to DNA. J Mol Biol. 2007;372:1227–45.
Tainio J, Jahnukainen K, Nurmio M et al. Testicular function, semen quality, and fertility in young men after renal transplantation during childhood and adolescence. Transplantation 2014;98:987–93.
Tainio J, Qvist E, Vehmas R, et al. Pubertal development is normal an adolescents after renal transplantation in childhood. Transplantation. 2011;92:404–9.
Tory K, Menyhard D, Woerner S, et al. Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotric syndrome. Nat Genet. 2014;46:299–304.
Toubiana J, Schlageter M, Aoun B, et al. Therapy-resistant anaemia in congenital nephrotic syndrome of the Finnish type-implication of EPO, transferrin and transcobalamin losses. Nephrol Dial Transplant. 2009;23:1338–40.
Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med. 2006;354:1387–401.
Vachvanishsanong P, Mitarnum W, Tungsinmunkong K, Disseneewate P. Congenital and infantile nephrotic syndrome in Thai infants. Clin Pediatr. 2005;44:169–74.
Van DeVoorde R, Witte D, Kogan J, Goebel J. Pierson syndrome: a novel cause of congenital nephrotic syndrome. Pediatrics. 2006;118:e501–5.
Wartiovaara J, Ofverstedt LG, Khoshnoodi J, et al. Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J Clin Invest. 2004;114:1475–83.
Winn M, Conlon P, Lynn K, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science. 2005;308:1801–4.
Wolf G, Stahl R. CD2-associated protein and glomerular disease. Lancet. 2003;362:1746–8.
Wong W, Morris M, Kara T. Congenital nephrotic syndrome with prolonged renal survival without renal replacement therapy. Pediatr Nephrol. 2013;28:2313–21.
Wuhl E, Kogan J, Zurowska A, et al. Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome. Am J Med Genet. 2007;143:311–9.
Yang Y, Jeanpirre C, Dressler G, et al. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome an isolated diffuse mesangial sclerosis. Am J Pathol. 1999;154:181–92.
Yao J, Le T, Kos C, et al. α-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol. 2004;2:787–94.
Xiao H, Liu J, Zhong X. Congenital syphilis presenting congenital nephrotic syndrome in two children and related data review. Beijing Da Xue Xue Bao. 2011;43:911–3.
Zenker M, Aigner T, Tralau T, et al. Human laminin b2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet. 2004;13:2625–32.
Zenker M, Tralau T, Lennert T, et al. Congenital nephrosis, mesangial sclerosis, and distinct eye abnormalities with microcoria: an autosomal recessive syndrome. Am J Med Genet. 2004;130:138–45.
Zhang A, Huang S. Progress in pathogenesis of proteinuria. Int J Nephrol 2012;ID314251.
Zhu J, Sun N, Aoujit L, et al. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int. 2008;73:556–66.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Jalanko, H., Holmberg, C. (2014). Congenital Nephrotic Syndrome. In: Avner, E., Harmon, W., Niaudet, P., Yoshikawa, N., Emma, F., Goldstein, S. (eds) Pediatric Nephrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27843-3_78-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-27843-3_78-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27843-3
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Congenital Nephrotic Syndrome- Published:
- 10 March 2022
DOI: https://doi.org/10.1007/978-3-642-27843-3_78-3
-
Original
Congenital Nephrotic Syndrome- Published:
- 24 November 2014
DOI: https://doi.org/10.1007/978-3-642-27843-3_78-1